Active Not RecruitingNCT04754061
Psilocybin microdosing for distress in advanced illness
About this title
Read the official source — NCT04754061Medication studyAges 18+CanadaAnxiety
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Ottawa and 1 more locationSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 8, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 20
- Sponsor
- Ottawa Hospital Research Institute
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT04754061
- Official title
Show the full official title
PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ottawa
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Ottawa Hospital Research Institute, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
